Clinical Trial Physician, Cell Therapy, Medical Evidence Generation

About this role

At Bristol Myers Squibb, our employees often ask, “Who are you working for?”—a question that fuels collaboration, accountability, and urgency in our work. Our purpose-driven culture inspires us to discover, develop, and deliver innovative medicines to prevail over serious diseases. We offer uniquely interesting and meaningful work, opportunities for growth, and a supportive environment that values inclusion, wellbeing, flexibility, and comprehensive benefits. This is work that transforms the lives of patients, and the careers of those who do it.

Position Summary

This Director, Medical Evidence Generation (MEG) Clinical Trial Physician (CTP) - Cell Therapy (CT) role in Medical Affairs manages the evidence generation for the CT portfolio (including Medical Affairs Sponsored studies [MAST]) and provides clinical support for other studies in the MEG book of work (BOW).  In this role, he/she will serve as the primary source of medical/clinical accountability and oversight for a MAST in alignment with the Integrated Evidence Plans (IEP) for the assets in Cell Therapy portfolio. He/she will work closely with Worldwide Medical (WWM) Cell Therapy Asset Lead, the MEG Cell Therapy Lead, and other members of the study team for the day-to-day oversight and conduction of the clinical studies included in the BOW for an asset in the Cell Therapy portfolio. The CT MEG CTP will lead and participate in cross-functional matrix leadership teams focused on building these relationships and actively sourcing research concepts that address critical evidence gaps for early and late assets being developed in prioritized indications. 

This role will report to the Cell Therapy MEG Lead and will be expected to:  • Provide medical/clinical accountability and oversight for the various medical affairs-led sponsored studies (interventional and non-interventional), in alignment with the Integrated Evidence Plans (IEP) for the assets in company’s portfolio.

• Collaborate with the TA Medical Lead, CT MEG Lead, Clinical Scientist (CS), and Global Trial Manager (GTM) for the development of the study protocol and ICF, authoring and providing medical input during protocol development.

• Partner with Clinical Scientist (CS) and Global Trial Manager (GTM) to support executional delivery of studies (e.g., clinical database development, clinical data oversight, site activation, enrollment status, as well as adjudication for protocol violations, significant, non-significant deviations etc.).

• Hold responsibility for assessment of key safety-related serious adverse events in partnership with Worldwide Patient Safety and oversees safety narratives (if applicable).

• Accountable for medical data review of trial data, including eligibility assessment and interpretation of trial data results.

• Provide medical oversight and accountability for the study-related work conducted by external partners (CROs), particularly related to medical monitoring-related activities.

• Provide continuous medical education in partnership with CTLs and T/A Medical Leads related to protocol-specific training (supporting the study team, investigators, CROs, and others).

• Provide medical expertise during Study Steering Committees, Investigators’ Meetings, and other study-related meetings with external audiences. Build relationships with principal investigators and other relevant external stakeholders.

• Responsible for partnering closely with key stakeholders across Medical, including the Clinical Research Collaborations group, working on the cell therapy portfolio to ensure cohesiveness and one MEG voice.

• Fulfill GCP and compliance obligations for clinical conduct and maintains all required training.

• Employ strong business acumen and fiscal stewardship focused on driving reciprocal scientific value creation and allocate resources consistent with company priorities.

Qualifications & Experience

• Established strategic leadership experience serving at least 5-10 years in a pharmaceutical industry setting and possessing an in-depth understanding of Clinical Development, Medical Affairs, and Commercial functions related to the drug development process.

• MD required (or x-US equivalent) plus 2-3 years of clinical trial experience, either in industry or academic setting; expertise in drug development process and clinical research; experience with implementation and conduction of medical affairs-led studies and/or cell therapy clinical development desirable.

• Adeptness at building credibility with external investigators and collaborative partners competently balancing business and scientific acumen complemented by strong leadership behaviors, authenticity, agility, and an enterprise mindset.

• Demonstrated ability to develop and sustain a high-performing team along with a proven ability to successfully lead teams (including matrix colleagues)

• Demonstrated track record of leadership in a complex, matrix environment.

• Exceptional communication and interpersonal skills to influence decision-making at all levels of the organization.

This Position is based at the Princeton Pike (PPK) or other sites in New Jersey; Expected travel ~20%-30% within the US.

#LI-HYBRID

We hire for skills and capabilities, not just credentials – if this role excites you, but doesn’t perfectly match your resume, we encourage you to apply anyway.

Compensation Overview:

Madison - Giralda - NJ - US: $253,390 - $307,043
Princeton - NJ - US: $253,390 - $307,043 
 The starting pay range(s) listed above is for full-time employees (FTE). You may also be eligible for additional discretionary incentive cash and stock opportunities. We determine starting pay thoughtfully – carefully considering the nature of the role, required skills, work location, schedule and the knowledge and experience you bring. Final compensation is guided by pay equity principles and applicable employment laws. Compensation programs are reviewed on an ongoing basis and may be adjusted over

Similar jobs

• Senior Clinical Project Manager (Cell & Gene Therapy) — IQVIA · Durham, North Carolina, United States
• Senior Scientist. Cell Therapy Process Development — AstraZeneca · MD, Gaithersburg
• Senior Scientist, Cell Therapy Genetic Regulation — Johnson & Johnson · Spring House, Pennsylvania, United States
• Associate Research Scientist (Cell & Gene Therapy) — Fresenius Kabi · Lake Zurich, IL | Illinois
• Senior Principal Scientist -Bioanalytical Assay- Cell Therapy — Roche · South San Francisco
• Physician - Hematologic Malignancies - Scientist - Immune Effector Cell Therapy — The University of Kansas Health System · Westwood, KS
• Senior Medical Science Liaison – Cell Therapy (Southern California) — AstraZeneca · CA, San Diego | CA, Los Angeles
• Associate Director, Bioanalysis (Cell Therapy) — AstraZeneca · US – Santa Monica Colorado Avenue – CA